Invention Grant
- Patent Title: Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
- Patent Title (中): 癌前病变和癌细胞的标志物以及干扰细胞增殖的方法
-
Application No.: US14479143Application Date: 2014-09-05
-
Publication No.: US09359648B2Publication Date: 2016-06-07
- Inventor: Luis Burzio , Jaime E. Villegas , Veronica A. Burzio
- Applicant: ANDES BIOTECHNOLOGIES S.A.
- Applicant Address: CL
- Assignee: Andes Biotechnoogies S.A.
- Current Assignee: Andes Biotechnoogies S.A.
- Current Assignee Address: CL
- Agency: Morrison & Foerster LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/02 ; C07H21/04 ; C07F9/6561 ; C12N15/11 ; C12N15/113 ; C12N5/09

Abstract:
A novel family of human mitochondrial RNAs, referred to as chimeric RNAs, which are differentially expressed in normal, pre-cancer and cancer cells, are described. Oligonucleotides targeted to the chimeric RNAs are provided. The described oligonucleotides or their analogs can be used for cancer diagnostics and cancer therapy as well as for research. In one embodiment of this invention, these oligonucleotides hybridize with the sense or with the antisense mitochondrial chimeric RNAs, and the result of the hybridization is useful to differentiate between normal proliferating cells, pre-cancer cells and cancer cells. In another embodiment of the invention, the compositions comprise oligonucleotides that hybridize with the human chimeric RNAs resulting in cancer cell and pre-cancer cell death, while there is no effect in normal cells, constituting therefore, a novel approach for cancer therapy.
Public/Granted literature
- US20150064700A1 MARKERS FOR PRE-CANCER AND CANCER CELLS AND THE METHOD TO INTERFERE WITH CELL PROLIFERATION THEREIN Public/Granted day:2015-03-05
Information query